Log In
BCIQ
Print this Print this
 

PAN-622

  Manage Alerts
Collapse Summary General Information
Company Panacea Pharmaceuticals Inc.
DescriptionHuman sequence mAb against human aspartyl (asparaginyl) beta-hydroxylase (HAAH)
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationLiver cancer
Indication DetailsTreat liver cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today